Showing results (201-210 of 298) with videos related to
Sort By:
Pageof 30
Molecular Cancer Therapeutics|December 30, 2025
In vivo Auto-tuning of Antibody-Drug Conjugate Delivery to Maximize Efficacy using High-Avidity, Low-Affinity AntibodiesAnna Kopp, Shujun Dong, Hyeyoung Kwon, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 17, 2013
Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitroXinyi Li, Xin Zhang, Ali Reza A Ladiwala, et al.Proceedings of the National Academy of Sciences of the United States of America|September 2, 2008
Heat shock factor 1 regulates lifespan as distinct from disease onset in prion diseaseAndrew D Steele, Gregor Hutter, Walker S Jackson, et al.Proceedings of the National Academy of Sciences of the United States of America|December 29, 2016
Suppression of 19S proteasome subunits marks emergence of an altered cell state in diverse cancersPeter Tsvetkov, Ethan Sokol, Dexter Jin, et al.Cancer Research|July 1, 2015
Endothelial Thermotolerance Impairs Nanoparticle Transport in TumorsAlexander F Bagley, Ruth Scherz-Shouval, Peter A Galie, et al.Cell|August 7, 2012
HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancersMarc L Mendillo, Sandro Santagata, Martina Koeva, et al.The Journal of Biological Chemistry|May 2, 2012
Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicityAli Reza A Ladiwala, Jeffrey Litt, Ravi S Kane, et al.Biorxiv : the Preprint Server for Biology|January 3, 2024
Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamilyHarkamal S Jhajj, John S Schardt, Namir Khalasawi, et al.Proceedings of the National Academy of Sciences of the United States of America|November 20, 2012
Rational design of potent domain antibody inhibitors of amyloid fibril assemblyAli Reza A Ladiwala, Moumita Bhattacharya, Joseph M Perchiacca, et al.Cell Chemical Biology|April 23, 2024
Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptorsHarkamal S Jhajj, John S Schardt, Namir Khalasawi, et al.Pageof 30